TARSTarsus Pharmaceuticals, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 22308
Ticker: TARS
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2020-10-16
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: TARS

Detail

Enriched 2026-08-14 20:47

Market cap: $3,072,467,964.94
Shares outstanding (class): 43,882,996
Shares outstanding (weighted): 43,882,996
SIC: 2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees: 370
Location: IRVINE, CA
Homepage: https://www.tarsusrx.com
Description: Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

Market cap and share counts drift.

Funds holding this security

130 funds · 133 positions · $549.29M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$89.94M	0.00%	1,282,126 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$67.84M	0.09%	967,067 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$30.53M	0.04%	435,258 NS	FIGI
PGIM Jennison Small Company Fund Prudential Jennison Small Co Fund, Inc.	—	$30.50M	0.96%	434,746 NS	FIGI
iShares Russell 2000 Growth ETF iShares Trust	IWO	$22.67M	0.19%	323,167 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$20.87M	0.26%	297,522 NS	FIGI
Janus Henderson Global Life Sciences Fund JANUS INVESTMENT FUND	—	$20.79M	0.40%	296,425 NS	FIGI
Janus Henderson Triton Fund JANUS INVESTMENT FUND	—	$19.57M	0.38%	279,029 NS	FIGI
Nomura Small Cap Growth Fund IVY FUNDS	—	$19.16M	1.95%	273,131 NS	FIGI
Loomis Sayles Small Cap Growth Fund LOOMIS SAYLES FUNDS II	—	$16.01M	0.83%	228,168 NS	FIGI
Artisan International Small-Mid Fund Artisan Partners Funds Inc.	—	$13.34M	0.50%	190,161 NS	FIGI
Invesco Main Street Small Cap Fund AIM Growth Series (Invesco Growth Series)	—	$13.09M	0.59%	186,547 NS	FIGI
T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC.	—	$12.34M	0.11%	175,856 NS	FIGI
Janus Henderson Venture Fund JANUS INVESTMENT FUND	—	$11.51M	0.38%	164,015 NS	FIGI
Putnam Small Cap Growth Fund Putnam Funds Trust	—	$9.24M	0.34%	131,761 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERTARS
FIGI_COMPOSITEBBG00RB9BNQ7
FIGI_SHARE_CLASSBBG00RB9BNR6
CIK0001819790
ISINUS87650L1035
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Tarsus Pharmaceuticals is a biopharmaceutical company developing therapies, classified under biological products.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.